Device for the transdermal delivery of diclofenac
First Claim
Patent Images
1. A pressure sensitive skin adhesive comprising:
- (a) a copolymer of one or more alkyl(meth)acrylates containing 4 to 12 carbon atoms in the alkyl group and one or more hydrophilic monomers;
(b) a mixture of penetration enhancers comprising;
(i) an alkyl ester of an aliphatic monocarboxylic acid containing 1 to 5 carbon atoms in the alkyl group;
(ii) an N-alkyl-2-pyrrolidone or a compound of the formula (I)
wherein R1 is H or alkyl and R2 is the residue of an aliphatic hydrocarbon and (iii) an alkane polyol; and
(c) a therapeutically effective amount of diclofenac or a pharmaceutically acceptable salt thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides a pressure sensitive skin adhesive comprising:
(a) a copolymer of one or more alkyl(meth)acrylates containing 4 to 12 carbon atoms in the alkyl group and one or more hydrophilic monomers;
(b) a mixture of penetration enhancers comprising:
(i) an alkyl ester of an aliphatic monocarboxylic acid containing 1 to 5 carbon atoms in the alkyl group
(ii) an alkyl pyrrolidone and
(iii) an alkane polyol
(c) a therapeutically effective amount of diclofenac or a pharmaceutically acceptable salt thereof.
Further provided is a transdermal drug delivery device containing the pressure sensitive skin adhesive.
-
Citations
14 Claims
-
1. A pressure sensitive skin adhesive comprising:
-
(a) a copolymer of one or more alkyl(meth)acrylates containing 4 to 12 carbon atoms in the alkyl group and one or more hydrophilic monomers;
(b) a mixture of penetration enhancers comprising;
(i) an alkyl ester of an aliphatic monocarboxylic acid containing 1 to 5 carbon atoms in the alkyl group;
(ii) an N-alkyl-2-pyrrolidone or a compound of the formula (I)
wherein R1 is H or alkyl and R2 is the residue of an aliphatic hydrocarbon and(iii) an alkane polyol; and
(c) a therapeutically effective amount of diclofenac or a pharmaceutically acceptable salt thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
wherein R1 is H or alkyl and R2 is the residue of an aliphatic hydrocarbon; and
between 20 and 45% by weight of said alkane polyol.
-
-
11. A pressure sensitive skin adhesive according to claim 1 wherein the diclofenac or pharmaceutically acceptable salt thereof is diclofenac sodium.
-
12. A pressure sensitive skin adhesive according to claim 1 wherein the diclofenac or pharmaceutically acceptable salt thereof is present in an amount of about 3 to 8 percent by weight based on the total weight of said pressure sensitive skin adhesive.
-
13. A transdermal drug delivery device comprising on a backing an adhesive layer comprising the pressure sensitive skin adhesive according to claim 1.
-
14. A method of treating inflammation or relieving pain in a subject comprising placing a pressure sensitive skin adhesive according to claim 1 in contact with the skin of the subject and allowing the pressure sensitive skin adhesive to remain in contact with the skin for a time effective to establish or maintain a therapeutically effective blood level of diclofenac or a pharmaceutically acceptable salt thereof in the subject.
Specification